Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Progressive bilateral essential iris atrophy

M Kaiser-Kupfer, T Kuwabara, C Kupfer

    American Journal of Ophthalmology
    |March 1, 1977
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The land morphology approach to flood risk mapping: An application to Portugal.

    Journal of environmental management·2017
    Same author

    The metabolism of fatty acids in human Bietti crystalline dystrophy.

    Investigative ophthalmology & visual science·2001
    Same author

    A case of Alport's syndrome and retinal degeneration.

    Retina (Philadelphia, Pa.)·2001
    Same author

    The madurai intraocular lens study IV: posterior capsule opacification.

    American journal of ophthalmology·2000
    Same author

    Genetic linkage of Bietti crystallin corneoretinal dystrophy to chromosome 4q35.

    American journal of human genetics·2000
    Same author

    The National Eye Institute's low vision education program: improving quality of life.

    Ophthalmology·2000
    Same journal

    Reply to Comment on Visual Field Progression in Glaucoma Patients with Delayed Follow-Up.

    American journal of ophthalmology·2026
    Same journal

    Comment on: "Safety and efficiency reducing retinopathy of prematurity guideline sensitivity: an external validation using a large US-based dataset".

    American journal of ophthalmology·2026
    Same journal

    Reply to Comment on "Clinicopathological and Imaging Distinction Between Ocular Adnexal MALT Lymphoma and IgG4-Related Ophthalmic Disease".

    American journal of ophthalmology·2026
    Same journal

    Comment on: Visual Field Progression in Glaucoma Patients With Delayed Follow-Up.

    American journal of ophthalmology·2026
    Same journal

    Corneal sensitivity changes and nerve plexus abnormalities in noninfectious anterior uveitis.

    American journal of ophthalmology·2026
    Same journal

    Role of Menopausal Hormone Therapy on Strabismus, Strabismus Surgery, and Reoperation Rates.

    American journal of ophthalmology·2026
    See all related articles

    Essential iris atrophy, a progressive eye condition, was studied in a young man. Findings suggest decreased outflow facility, not vascular issues, may cause iris atrophy.

    Area of Science:

    • Ophthalmology
    • Pathology

    Background:

    • Essential iris atrophy is a rare, progressive condition affecting the iris.
    • Understanding its pathogenesis is crucial for diagnosis and treatment.

    Observation:

    • A 24-year-old man presented with bilateral progressive essential iris atrophy, asymmetric between eyes.
    • Histopathology of the more affected eye showed normal iris vessels with perivascular connective tissue accumulation.
    • Fluorescein angiography of the less affected eye revealed no vascular abnormalities.

    Findings:

    • Tonography revealed markedly decreased outflow facility in the affected eye.
    • No vascular abnormalities were identified in either the histopathology or fluorescein angiography.
    • The pathogenesis of essential iris atrophy does not appear to involve vascular abnormalities.

    Related Experiment Videos

    Implications:

    • This study suggests that impaired aqueous humor outflow may play a significant role in essential iris atrophy.
    • Further research is needed to elucidate the exact mechanisms and potential therapeutic targets.